Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1259-1266, March 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, Y. C.
Right arrow Articles by Ackerman, J. J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, Y. C.
Right arrow Articles by Ackerman, J. J. H.

Nonglycolytic Acidification of Murine Radiation-induced Fibrosarcoma 1 Tumor via 3-O-Methyl-D-glucose Monitored by 1H, 2H, 13C, and 31P Nuclear Magnetic Resonance Spectroscopy1

Yuying C. Hwang2, Seong-Gi Kim3, Jeffrey L. Evelhoch and Joseph J. H. Ackerman4

Department of Chemistry, Washington University, St. Louis, Missouri 63130-4899 [Y. C. H., S-G. K., J. J. H. A.], and Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201 [J. L. E.]

The effects of 3-O-methyl-D-glucose (3-OMG) on subcutaneously implanted murine radiation-induced fibrosarcoma 1 tumor were examined with 2H, 13C, and 31P nuclear magnetic resonance (NMR) in situ. Using 31P NMR, changes in tumor high-energy phosphate metabolism were monitored for 2.5 h after i.p. administration of 3-OMG (8.1 g/kg body weight); tumor pH decreased by a mean maximum of 0.52 ± 0.05 (SE) (n = 10), [PCr] decreased by 54%, [NTP] decreased by 35%, and [P1] increased by 36%. Tumor blood flow, as measured by 2H NMR monitoring of D2O washout kinetics, decreased by 40% at 1 h and by 47% at 2 h after 3-OMG injection (n = 4). This substantial tumor acidification (pH decrease >> 0.1), expected to require a glycolytic substrate (Hwang et al., Cancer Res., 51: 3108–3118, 1991), is surprising in light of the previously documented metabolically inert nature of 3-OMG. In situ 13C NMR spectroscopy, following [6-13C]3-OMG i.p. injection, examined the possibility of the glycolytic metabolism of 3-OMG. However, only the C-6 resonance of 3-OMG was detected (n = 6); no resonances from [6-13C]3-OMG-6-phosphate or [3-13C]lactate were observed. These results confirmed that 3-OMG was not metabolized in radiation-induced fibrosarcoma 1 tumor. At the completion of the in situ 13C NMR experiments, tumors were freeze clamped, and perchloric acid extraction was performed. High-resolution 1H NMR measurement of lactate concentrations showed no statistically significant difference in control tumor extracts (from mice not receiving i.p. injection; n = 5) and in tumor extracts from mice administered i.p. [6-13C]3-OMG (n = 5), indicating that there was no significant increase in lactate level in the tumor extracts from mice administered i.p. 3-OMG due to increased plasma glucose concentration. The results of these 1H and 13C NMR studies indicated that the radiation-induced fibrosarcoma 1 tumor acidification caused by i.p. administration of 3-OMG was not due to a direct (3-OMG -> lactate) or an indirect (systemic glucose -> lactate) increase in tumor lactic acid levels.

1 Support for this work was provided by NIH Grants CA40411 and GM30331 and National Science Foundation Instrument Grant CHE-8100211.

2 Present address: Kettering-Scott Magnetic Resonance Laboratory, Kettering Medical Center and Department of Medicine, Wright State University School of Medicine, 3535 Southern Boulevard, Kettering, OH 45429.

3 Present address: Center for Magnetic Resonance Research, University of Minnesota School of Medicine, 385 East River Road, Minneapolis, MN 55455.

4 To whom requests for reprints should be addressed, at Department of Chemistry, Campus Box 1134, Washington University, I Brookings Drive, St. Louis, MO 63130-4899.

Received 7/ 9/91. Accepted 12/16/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Pospisil, K. Wang, A. F. Al Aowad, L. K. Iyer, S. J. Adelstein, and A. I. Kassis
Computational Modeling and Experimental Evaluation of a Novel Prodrug for Targeting the Extracellular Space of Prostate Tumors
Cancer Res., March 1, 2007; 67(5): 2197 - 2205.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.